| Name | Title | Contact Details |
|---|---|---|
Ingo Stecher |
Project Director (PMP), Engineering & Technology Americas | Profile |
Ozlem Arisoy |
VP IT Pharma Commercial Global | Profile |
Daria Yowe |
Principle Experience Lead - Laboratories | Profile |
Phoong Tang |
CIO, Head of Digital Transformation, Enabling Functions | Profile |
Destry Harmon |
Head of Digital Process Transformation | Profile |
We dont just treat cancer, we treat people. You can count on us to put you first and provide the most advanced treatments. Lets beat this together.
Option Care is a leading provider of home and alternate treatment site infusion services. With a staff of more than 1,700 clinical experts – including specially trained infusion nurses, infusion pharmacists and registered dietitians – Option Care treats patients with a wide range of acute and chronic conditions. Comprehensive therapy management programs are offered for patients with nutrition disorders, bleeding disorders and heart failure, as well as those needing immunoglobulin (IG) therapy and anti-infective therapy. Option Care is able to provide services to 92% of the nation`s population through more than 90 infusion pharmacies and 100 alternate treatment sites across the country.
Shionogi Pharma is a Florham Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Anuncia Medical, Inc., an emerging leader in Cerebrospinal Fluid (CSF) management
Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. Slayback has created a unique portfolio of complex generics by smart product selection and execution and connecting various dots through a network of contract R&D laboratories and manufacturing organizations, comprising smart and rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies.